176 related articles for article (PubMed ID: 21320018)
1. Predictors of long-term survival in dogs with high-grade multicentric lymphoma.
Marconato L; Stefanello D; Valenti P; Bonfanti U; Comazzi S; Roccabianca P; Caniatti M; Romanelli G; Massari F; Zini E
J Am Vet Med Assoc; 2011 Feb; 238(4):480-5. PubMed ID: 21320018
[TBL] [Abstract][Full Text] [Related]
2. The staging and treatment of multicentric high-grade lymphoma in dogs: a review of recent developments and future prospects.
Marconato L
Vet J; 2011 Apr; 188(1):34-8. PubMed ID: 20627636
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of leukemic blood and bone marrow in dogs with multicentric lymphoma.
Raskin RE; Krehbiel JD
J Am Vet Med Assoc; 1989 May; 194(10):1427-9. PubMed ID: 2470709
[TBL] [Abstract][Full Text] [Related]
4. Lomustine and prednisone as a first-line treatment for dogs with multicentric lymphoma: 17 cases (2004-2005).
Sauerbrey ML; Mullins MN; Bannink EO; Van Dorp TE; Kaneene JB; Obradovich JE
J Am Vet Med Assoc; 2007 Jun; 230(12):1866-9. PubMed ID: 17571992
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the effects of asparaginase administered subcutaneously versus intramuscularly for treatment of multicentric lymphoma in dogs receiving doxorubicin.
Valerius KD; Ogilvie GK; Fettman MJ; Walton JA; Richardson K; Powers BE; McNiel EA; Rogers QR
J Am Vet Med Assoc; 1999 Feb; 214(3):353-6. PubMed ID: 10023395
[TBL] [Abstract][Full Text] [Related]
6. Principles of treatment for canine lymphoma.
Ettinger SN
Clin Tech Small Anim Pract; 2003 May; 18(2):92-7. PubMed ID: 12831068
[TBL] [Abstract][Full Text] [Related]
7. Association of argyrophilic nucleolar organizing regions, Ki-67, and proliferating cell nuclear antigen scores with histologic grade and survival in dogs with soft tissue sarcomas: 60 cases (1996-2002).
Ettinger SN; Scase TJ; Oberthaler KT; Craft DM; McKnight JA; Leibman NF; Charney SC; Bergman PJ
J Am Vet Med Assoc; 2006 Apr; 228(7):1053-62. PubMed ID: 16579784
[TBL] [Abstract][Full Text] [Related]
8. Doxorubicin alone or in combination with asparaginase, followed by cyclophosphamide, vincristine, and prednisone for treatment of multicentric lymphoma in dogs: 121 cases (1987-1995).
Valerius KD; Ogilvie GK; Mallinckrodt CH; Getzy DM
J Am Vet Med Assoc; 1997 Feb; 210(4):512-6. PubMed ID: 9040837
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of bone marrow aspirates from multiple sites for staging of canine lymphoma and mast cell tumours.
Aubry OA; Spangler EA; Schleis SE; Smith AN
Vet Comp Oncol; 2014 Mar; 12(1):58-66. PubMed ID: 22577893
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of a continuous, multiagent chemotherapeutic protocol versus a short-term single-agent protocol in dogs with lymphoma.
Simon D; Moreno SN; Hirschberger J; Moritz A; Kohn B; Neumann S; Jurina K; Scharvogel S; Schwedes C; Reinacher M; Beyerbach M; Nolte I
J Am Vet Med Assoc; 2008 Mar; 232(6):879-85. PubMed ID: 18341445
[TBL] [Abstract][Full Text] [Related]
11. Assessment of anemia as an independent predictor of response to chemotherapy and survival in dogs with lymphoma: 96 cases (1993-2006).
Abbo AH; Lucroy MD
J Am Vet Med Assoc; 2007 Dec; 231(12):1836-42. PubMed ID: 18081522
[TBL] [Abstract][Full Text] [Related]
12. Cytological lymph node evaluation in dogs with mast cell tumours: association with grade and survival.
Krick EL; Billings AP; Shofer FS; Watanabe S; Sorenmo KU
Vet Comp Oncol; 2009 Jun; 7(2):130-8. PubMed ID: 19453367
[TBL] [Abstract][Full Text] [Related]
13. The diagnostic assessment of canine lymphoma: implications for treatment.
Bienzle D; Vernau W
Clin Lab Med; 2011 Mar; 31(1):21-39. PubMed ID: 21295720
[TBL] [Abstract][Full Text] [Related]
14. Clinical and pathologic findings in ferrets with lymphoma: 60 cases (1982-1994).
Erdman SE; Brown SA; Kawasaki TA; Moore FM; Li X; Fox JG
J Am Vet Med Assoc; 1996 Apr; 208(8):1285-9. PubMed ID: 8635973
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and prognostic impact of hypocobalaminemia in dogs with lymphoma.
Cook AK; Wright ZM; Suchodolski JS; Brown MR; Steiner JM
J Am Vet Med Assoc; 2009 Dec; 235(12):1437-41. PubMed ID: 20001778
[TBL] [Abstract][Full Text] [Related]
16. A retrospective study of the incidence and prognostic factors of multicentric lymphoma in dogs (1998-2000).
Jagielski D; Lechowski R; Hoffmann-Jagielska M; Winiarczyk S
J Vet Med A Physiol Pathol Clin Med; 2002 Oct; 49(8):419-24. PubMed ID: 12450190
[TBL] [Abstract][Full Text] [Related]
17. Retrospective survey of malignant lymphoma cases in the dog: clinical, therapeutical and prognostic features.
Gavazza A; Lubas G; Valori E; Gugliucci B
Vet Res Commun; 2008 Sep; 32 Suppl 1():S291-3. PubMed ID: 18704736
[No Abstract] [Full Text] [Related]
18. Outcome and toxicity associated with a dose-intensified, maintenance-free CHOP-based chemotherapy protocol in canine lymphoma: 130 cases.
Sorenmo K; Overley B; Krick E; Ferrara T; LaBlanc A; Shofer F
Vet Comp Oncol; 2010 Sep; 8(3):196-208. PubMed ID: 20691027
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors for malignant lymphoma in the dog: an update.
Teske E
Vet Q; 1994 Apr; 16 Suppl 1():29S-31S. PubMed ID: 7801464
[No Abstract] [Full Text] [Related]
20. Evaluation of a multidrug chemotherapy protocol with mitoxantrone based maintenance (CHOP-MA) for the treatment of canine lymphoma.
Daters AT; Mauldin GE; Mauldin GN; Brodsky EM; Post GS
Vet Comp Oncol; 2010 Mar; 8(1):11-22. PubMed ID: 20230577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
